News & Events
News
ISF Grants awarded to three Migal Senior Researchers
16-08-2021
We are excited to share with you the achievement of three researchers from the MIGAL- Galilee research Institute in the prestigious ISF grant.
ISF, the National Science Foundation, has been a leading force in different research fields in Israel for several decades, and supports a wide range of research areas, including exact sciences and technology, life sciences and medicine, humanities and social sciences.
Research Groups
We are proud to share with you our Algae4IBD project that received the EU grant
28-06-2021
We thank the EU and are proud to share the following algae video for the IBD project at the MIGAL Institute. The project received an impressive grant of 7.5 million euros to further fund the research of Dr. Dorit Avni, lead researcher at the MIGAL Institute, in the field of algae and coordinator of Algae4IBD.
Algae4IBD focused on the treatment of inflammatory bowel disease (IBD), including Crohn's and colitis, and their prevention.
How does advanced practical research influence the Galilee ecosystem & local community?
13-04-2021
We are proud to show you a new video we have produced.
The Migal Research Institute engages in advanced practical research as part of the Galilee ecosystem and the local community.
We researched, discovered, filmed, edited (well, not alone) and produced a video that gives a glimpse into our research activities.
We are excited to share with you our progress and collaborative relationships.
Worth watching!
Migal's Year in Review 2020
European Scientists' Night in Israel 2020 - online at Zoom!
03-12-2020
Migal Institute for Scientific Research in the Galilee invites you and you to an evening that is all about science On Thursday 3/12 between the hours of 16: 00-23: 00.
This year you will sit at home, tour our virtual space and choose from a variety of activities we have prepared for you: scientific experiments for the whole family, quizzes, an exhibition tour, lectures, demonstrations, a round table discussion with researchers and more. To enter, click on the link http://madalay.la/migal
ENABLING Project ends after 36 months of Active engagement in the Bioeconomy
29-11-2020
European Union’s Horizon 2020
PRESS RELEASE
Final Conference
The ENABLING Final Conference was held at EIMA Digital Preview on November 13, 2020. The EIMA Digital Preview -was the virtual fair organised by Federunacoma as a pre-event to the EIMA International Fair 2020, which was to be held in November. EIMA will now be held in February 2021, due to COVID-19 related impediments.
Migal took part in the inauguration of the Pafos Innovation Institute
05-11-2020
The Pafos Innovation Institute (PII) for higher education
Senior researcher Prof. Michael (Iggy) Litaur will lead the academic and the scientific aspects of the Integrative Water Management Program for postgraduate degrees: MBA MA and will be managed by IDC, in collaboration with other leading institutions and researchers from the Middle East and the world.
Researchers
Call for Senior Research Scientist positions
01-10-2020
Migal Galilee Research Institute Ltd
MIGAL Galilee Research Institute invites applicants for a Research Group Leader position in the following disciplinary areas: Organic Chemistry, Soil Chemistry, Computational/Synthetic Biology, Immunology, Plant Sciences/Health food value, Plant Genomics
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
01-03-2020
Biochemical Pharmacology
Patrik Prša, Betül Karademir, Gökhan Biçim, Hatem Mahmoud, Inbal Dahan, Süha Yalçın, Jamal Mahajna, Irina Milisava (2019). The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemical Pharmacology, Volume 173.
Researchers
Research Groups
Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute
07-09-2020
TRENDS Research and Advisory
Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine
By Dana Elimelech
Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19
14-09-2020
SoftNews
The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.
Researchers
Research Groups
Zebrafish help scientists speed up tests for medical cannabis strains
09-09-2020
ISRAEL 21c
Unusual research approach speeds up discovery of which cannabis plants work best for which medical indications.
Different strains of cannabis are helpful for treating different medical conditions. Testing each type for its therapeutic potential using mice or people is time-consuming.
WARNING!! Fraud Notice – Covid-19 Product
26-05-2020
Migal Galilee Research Institute Ltd., Migvax Ltd.
We have just been made aware that a fake pharmaceutical product allegedly for use in connection with COVID-19 is fraudulently being advertised and apparently sold in South America with the logo of Migal and with the following wording: " COVID-19 vaccine tracker. Cutting edge Israeli Biotech innovating coronavirus immunotherapy treatments." A photograph appears below.
Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine
27-02-2020
Israel’s Ministry of Science & Technology
After four years of research funded by Israel’s Ministry of Science & Technology, MIGAL’s researchers have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), to be adapted soon and create a human vaccine against COVID-19
COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel
19-03-2020
Por Márcio Juliboni
Contra o tempo: cientistas israelenses afirmam estar perto de obter vacina contra o coronavírus (Imagem: Unsplash/@cdc)
Uma vacina contra o coronavírus pode ser criada em 90 dias. A afirmação foi feita por David Zigdon, CEO do Galilee Research Institute (Migal), localizado na Galileia, em Israel. Zigdon participou de uma entrevista coletiva nesta quinta-feira (27), junto com sua equipe, para anunciar avanços nas pesquisas.
COVID-19
28-02-2020
Newsweek
CORONAVIRUS VACCINE 'WEEKS' AWAY FROM BEING DEVELOPED, SAYS HEAD OF ISRAELI SCIENCE RESEARCH INSTITUTE
The new virus that has killed over 2,800 people is a member of the large coronavirus family of pathogens, which also includes SARS and MERS.
Researchers
Research Groups